Scarica l'app Stockscreener
3.1584
7.20%
-0.245
Impact BioMedical, Inc. Borsa (IBO) Ultime notizie
Stock splits calendar for: - Yahoo Finance Australia
Form 4 Impact Biomedical Inc For: 24 September By Investing.com - Investing.com India
10% Owner Inc. Dss, Sells 906 Shares of Impact BioMedical Inc (I - GuruFocus
Form 4 Impact Biomedical Inc For: 24 September By Investing.com - Investing.com Canada
DSS Inc., 10% owner, sells $1,686 in Impact Biomedical stock By Investing.com - Investing.com South Africa
DSS Inc., 10% owner, sells $1,686 in Impact Biomedical stock - Investing.com
DSS Inc., 10% owner, sells $1,686 in Impact Biomedical stock By Investing.com - Investing.com India
DSS Inc., 10% owner, sells $1,686 in Impact Biomedical stock By Investing.com - Investing.com Canada
DSS Inc., 10% owner, sells $1,686 in Impact Biomedical stock By Investing.com - Investing.com UK
Across three days, DSS sold 906 Impact Biomedical (IBO) shares at prices from $0.55 to $7.0587. - Stock Titan
Impact Biomedical executes 1-for-12.62 reverse stock split ahead of Zoar Ltd. merger - Pluang
Impact BioMedical (IBO) moves toward Zoar merger vote - Stock Titan
DSS Says Zoar Files Form F-4 for Impact Biomedical Combination - citybiz.co
Impact Biomedical files F-4 for business combination - Investing.com
Impact Biomedical Inc. Announces Filing of F-4 Registration Statement for Proposed Business Combination with Zoar Limited - Quiver Quantitative
DSS Announces Filing of Form F-4 by Zoar Limited in Connection with Proposed Business Combination with Impact Biomedical - Quiver Quantitative
DSS, Inc. Announces Form F-4 Filing in Connection with Impact Biomedical’s Proposed Business Combination with Zoar Limited - Yahoo Finance
Impact Biomedical Inc Announces Filing of Form F-4 - GlobeNewswire
Impact Biomedical Inc Announces Filing of Form F-4 Registration Statement in Connection with Proposed Merger with Zoar Ltd. (f/k/a Dr. Ashley’s Limited) - Yahoo Finance
Impact Biomedical files F-4 for business combination By Investing.com - Investing.com UK
Impact Biomedical's proposed merger could create a company developing and supplying drug ingredients - Stock Titan
A proposed deal involving Impact Biomedical reaches U.S. regulators. It is not approved yet. - Stock Titan
IBO: Impact BioMedical Inc. Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Impact Biomedical approves 1-for-12.62 reverse stock split ahead of proposed Zoar merger - TradingView
Impact BioMedical (NYSE: IBO) shrinks share count ahead of proposed Zoar merger - Stock Titan
Impact Biomedical expects shares to fall from about 107.8 million to 8.54 million - Stock Titan
Impact Biomedical corrects merger exchange ratio, sets reverse stock split - Investing.com
CORRECTED — Impact Biomedical Inc (NYSE: IBO) Announces 1 - GlobeNewswire
Impact Biomedical Announces 1-for-12.62 Reverse Stock Split Ahead of Proposed Zoar Limited Merger - Moomoo
CORRECTED — Impact Biomedical Inc (NYSE: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Limited (f/k/a Dr Ashleys Limited) - Yahoo Finance
Impact BioMedical approves 1-for-12.62 reverse stock split - Investing.com
Impact BioMedical Announces 1-for-12.62 Reverse Stock Split Ahead of Proposed Zoar Merger - Quiver Quantitative
Impact BioMedical Inc (NYSE American: IBO) Announces 1 for - GlobeNewswire
About 108 million shares are expected to become 8.5 million as Impact BioMedical pursues a proposed merger. - Stock Titan
Impact BioMedical to Effect 1-for-12.62 Reverse Stock Split - marketscreener.com
Impact BioMedical Inc (NYSE American: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Ltd. (previously Dr. Ashley’s Ltd.) - Yahoo Finance
Impact BioMedical, Inc. (IBO) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
IBO - Finviz
Rosen Law Firm Encourages Impact Biomedical Inc. Investors to Inquire About Securities Class Action Investigation – IBO - Business Wire
Impact BioMedical Inc. Reports Going Concern Audit Opinion - GlobeNewswire
Impact BioMedical Inc. Reports "Going Concern" Qualification in Annual 10-K Audit Opinion and Plans Merger with Dr. Ashley's Ltd. - Quiver Quantitative
Impact Biomedical (IBO) 10K Form and Latest SEC Filings 2026 - MarketBeat
Grady Jason sells Impact Biomedical (IBO) stock worth $32,505 - Investing.com
Impact BioMedical Advances Dr Ashleys Combination With Amended Terms, Holder Support and DSS Funding - TradingView
1.35%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):